In today’s briefing:
- Fadu IPO Trading – Strong Subscription Rates Compared to Recent Korean IPOs
- Concord Biotech IPO – Peer Comparison & Valuation – Smaller in Scale but Wider in Margins
- Naver Webtoon to List on NASDAQ in 2024
Fadu IPO Trading – Strong Subscription Rates Compared to Recent Korean IPOs
- Fadu (440110 KS) raised US$151m in its Korean IPO, after the deal was priced at KRW31,000/share, the top end of its IPO price range.
- Fadu is a South Korean fabless semiconductor maker mainly engaged in flash storage technology innovation. Its core products are Enterprise Solid State Drive (SSD) and Enterprise SSDs.
- In this note, we will talk about the demand for the deal and other trading dynamics.
Concord Biotech IPO – Peer Comparison & Valuation – Smaller in Scale but Wider in Margins
- Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO.
- Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).
- In this note, we will undertake a peer comparison, and share our thoughts on valuation.
Naver Webtoon to List on NASDAQ in 2024
- Naver Corp (035420 KS) is planning to complete an IPO of Naver Webtoon on NASDAQ in 2024.
- Naver Webtoon generated sales of 548.9 billion won (up 54.5% YoY) and net profit of 68.6 billion won (up 17.1% YoY) in 2022.
- Naver Corp’s Contents unit which includes the Naver Webtoon business posted solid revenue growth of 40.1% YoY to reach 420.4 billion won in 2Q 2023.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
